C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2006
08/24/2006	US20060191037 Plant transcription factor that is involved in sugar signalling
08/24/2006	US20060191034 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
08/24/2006	US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof
08/24/2006	US20060191024 Method for preparing anti-MIF antibodies
08/24/2006	US20060189798 Novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor
08/24/2006	US20060189797 Magnetic polymer particles
08/24/2006	US20060189795 Use of ph-responsive polymers
08/24/2006	US20060189793 Methods and compositions for inhibiting neoplastic cell growth
08/24/2006	US20060189792 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
08/24/2006	US20060189791 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof
08/24/2006	US20060189790 Removal of lipopolysaccharides from protein-lipopolysaccharide complexes by non flammable solvents.
08/24/2006	US20060189563 Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
08/24/2006	US20060189558 Delivery of substances to cells
08/24/2006	US20060189540 Detection of toxic gluten oligopeptides refractory to digestion and antibodies and T cells responsive thereto can be used to diagnose Celiac Sprue
08/24/2006	US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
08/24/2006	US20060189537 Peptides for detection of antibody to Ehrlichia ewingii
08/24/2006	US20060189531 Thrombopoietic compounds
08/24/2006	US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences
08/24/2006	US20060189528 Osteoprotegerin variant proteins
08/24/2006	US20060189525 DADD, death activator death domain protein
08/24/2006	US20060189521 Human Liver Regeneration Associated Protein and the Use Thereof
08/24/2006	US20060189520 Treatment of diabetes
08/24/2006	US20060189519 Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
08/24/2006	US20060189518 Preventing/remedies for cancer
08/24/2006	US20060189516 Method for producing cross-linked hyaluronic acid-protein bio-composites
08/24/2006	US20060189515 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin
08/24/2006	US20060189001 Ssx-2 peptides presented by hla class II molecules
08/24/2006	US20060188991 Flexible vaccine assembly and vaccine delivery platform
08/24/2006	US20060188990 Novel prostate tumor-specific promoter
08/24/2006	US20060188975 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
08/24/2006	US20060188972 Targeted modification of chromatin structure
08/24/2006	US20060188964 Processing for producing and crystallizing G-protein coupled receptors
08/24/2006	US20060188963 Collectin-complement activating protein chimeras
08/24/2006	US20060188962 19 human secreted proteins
08/24/2006	US20060188960 Chimeric histamine H3 receptor
08/24/2006	US20060188959 Crystal structure of worm NitFhit reveals that a Nit tetramer binds tow Fhit dimers
08/24/2006	US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
08/24/2006	US20060188956 Relaxin3-gpcr135 complexes and their production and use
08/24/2006	US20060188944 Methods of assaying receptor activity
08/24/2006	US20060188937 G-protein estrogen membrane receptor
08/24/2006	US20060188933 IRAK-M is a negative regulator of toll-like receptor signaling
08/24/2006	US20060188930 Isolated fluorescent protein from clytia gregaria cgfp and use thereof
08/24/2006	US20060188925 polynucleotides that encoding a cytotoxic T-lymphocyte associated protien-4 (CTLA-4) receptor, used as vaccines
08/24/2006	US20060188924 TCL-1 gene and protein and related methods and compositions
08/24/2006	US20060188923 Novel human parvovirus B19 receptor and uses thereof
08/24/2006	US20060188919 Nucleic acid sequences having characteristics of enhanced expression in human neuroblastoma with favorable prognosis based on comparison between human neuroblastoma with favorable prognosis and human neuroblastoma with unfavorable prognosis
08/24/2006	US20060188915 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis
08/24/2006	US20060188914 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/24/2006	US20060188884 for use in second generation HIV vaccines and as diagnostic tools in the treatment and control of HIV infection; define a critical balance between MHC affinity and receptor crossreactivity required for effective epitope enhancement and also demonstrate construction and efficacy of
08/24/2006	US20060188882 Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
08/24/2006	US20060188879 Crh responsive genes in cns
08/24/2006	US20060188872 Novel post-transcriptional regulatory elements and uses thereof
08/24/2006	US20060188527 Methods for vaccinating against malaria
08/24/2006	US20060188524 Canine vaccine for protection against ehrlichiosis
08/24/2006	US20060188522 Viral agents
08/24/2006	US20060188518 Glycoconjugate vaccines for use in immune-compromised populations
08/24/2006	US20060188516 Chlamydia trachomatis antigens
08/24/2006	US20060188515 Polypeptides for inducing a protective immune response against staphylococcus aureus
08/24/2006	US20060188514 Products specific to pathogenic strains and their use as vaccines and in immunotherapy
08/24/2006	US20060188513 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
08/24/2006	US20060188504 Interleukin-13 as a cardiovascular disease marker
08/24/2006	US20060188497 Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activity
08/24/2006	US20060188484 Virus vectors and methods of making and administering the same
08/24/2006	US20060188483 Virus vectors and methods of making and administering the same
08/24/2006	US20060188478 Glycosylated interferon
08/24/2006	US20060188474 Interleukin 1beta protease and interleukin 1beta protease inhibitors
08/24/2006	US20060188472 HAS-active ingredient conjugates
08/24/2006	US20060188446 T-cell epitope peptides
08/24/2006	US20060188441 Radiolabeled gallium complexes, methods for synthesis and use for PET imaging of EGFR expression in malignant tumors
08/24/2006	US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery
08/24/2006	DE60115613T2 Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien Production of recombinant muteins of the blood coagulation factor viii in human cell lines
08/24/2006	DE4192786B4 Masernvirus-Rekombinanter Pockenvirus-Impfstoff Measles virus recombinant poxvirus vaccine
08/24/2006	DE20023789U1 Novel synthetic intermediate compounds useful for preparing modified peptides and peptide conjugates which are useful in biosensors for detecting the location of cellular proteins in living cells
08/24/2006	DE102005008102A1 Polynucleotide useful for coating a nano velcro medical threads, comprising a mature form coded fragment/polypeptide derivative with derived amino acid sequence and a coding sequence
08/24/2006	DE102005005438A1 Mutanten des fluoreszierenden Proteins CGFPs, sowie deren Verwendung Mutants of the fluorescent protein CGFPs, and their use
08/24/2006	DE10154254B4 Abdichtungsanordnung The seal assembly
08/24/2006	CA2621047A1 Method of treating eye injury with local administration of a vegf inhibitor
08/24/2006	CA2601924A1 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
08/24/2006	CA2598570A1 Methods for producing proteins using hamster igf-1
08/24/2006	CA2598535A1 Anti her2/neu antibody
08/24/2006	CA2598121A1 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor
08/24/2006	CA2598090A1 Synergistic effect of tgf-beta blockade and immunogenic agents on tumors
08/24/2006	CA2598080A1 Amyloid-binding peptides, analogues and uses thereof
08/24/2006	CA2597980A1 Polypeptides having alpha-amylase and granular starch hydrolyzing activity
08/24/2006	CA2597958A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
08/24/2006	CA2597795A1 A molecule and chimeric molecules thereof
08/24/2006	CA2597605A1 Pharmaceutical compositions for treating or preventing bone conditions
08/24/2006	CA2597584A1 Molecules and chimeric molecules thereof
08/24/2006	CA2597263A1 Polypeptides from staphylococcus aureus and methods of use
08/24/2006	CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
08/24/2006	CA2595877A1 Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
08/24/2006	CA2594490A1 Methods of treating skin disorders using an il-31ra antagonist
08/24/2006	CA2582164A1 Cupredoxin derived transport agents and methods of use thereof
08/23/2006	EP1693673A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis
08/23/2006	EP1693457A2 Metastatic breast and colon cancer regulated genes
08/23/2006	EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof
08/23/2006	EP1693455A1 Simian orl1 gene and method of assessing compound
08/23/2006	EP1693451A1 Method of growing myocardial cells
08/23/2006	EP1693449A1 Cell-free notch cleavage analysis method and drug screening method
08/23/2006	EP1693382A2 Melanocortin 1 receptor selective compounds

1 ... 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 ... 2916